85 related articles for article (PubMed ID: 12120238)
1. Pancreatic cancer genetics.
Efthimiou E; Crnogorac-Jurcevic T; Lemoine NR
Pancreatology; 2001; 1(6):571-5. PubMed ID: 12120238
[TBL] [Abstract][Full Text] [Related]
2. Familial pancreatic cancer: from genes to improved patient care.
Hruban RH; Klein AP; Eshleman JR; Axilbund JE; Goggins M
Expert Rev Gastroenterol Hepatol; 2007 Oct; 1(1):81-8. PubMed ID: 19072437
[TBL] [Abstract][Full Text] [Related]
3. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas.
Goggins M; Schutte M; Lu J; Moskaluk CA; Weinstein CL; Petersen GM; Yeo CJ; Jackson CE; Lynch HT; Hruban RH; Kern SE
Cancer Res; 1996 Dec; 56(23):5360-4. PubMed ID: 8968085
[TBL] [Abstract][Full Text] [Related]
4. [Familial pancreatic cancer].
Zalatnai A
Magy Onkol; 2006; 50(2):163-8. PubMed ID: 16888680
[TBL] [Abstract][Full Text] [Related]
5. Identification of high-risk pancreatic cancer-prone families.
Brand RE; Lynch HT
Gastroenterol Clin North Am; 2004 Dec; 33(4):907-18. PubMed ID: 15528025
[TBL] [Abstract][Full Text] [Related]
6. Patients with both pancreatic adenocarcinoma and melanoma may harbor germline CDKN2A mutations.
Lal G; Liu L; Hogg D; Lassam NJ; Redston MS; Gallinger S
Genes Chromosomes Cancer; 2000 Apr; 27(4):358-61. PubMed ID: 10719365
[TBL] [Abstract][Full Text] [Related]
7. CDKN2A is the main susceptibility gene in Italian pancreatic cancer families.
Ghiorzo P; Fornarini G; Sciallero S; Battistuzzi L; Belli F; Bernard L; Bonelli L; Borgonovo G; Bruno W; De Cian F; Decensi A; Filauro M; Faravelli F; Gozza A; Gargiulo S; Mariette F; Nasti S; Pastorino L; Queirolo P; Savarino V; Varesco L; Scarrà GB;
J Med Genet; 2012 Mar; 49(3):164-70. PubMed ID: 22368299
[TBL] [Abstract][Full Text] [Related]
8. Clinical and genetic analysis of 18 pancreatic carcinoma/melanoma-prone families.
Bartsch DK; Langer P; Habbe N; Matthäi E; Chaloupka B; Sina M; Hahn SA; Slater EP
Clin Genet; 2010 Apr; 77(4):333-41. PubMed ID: 20041885
[TBL] [Abstract][Full Text] [Related]
9. Familial melanoma, pancreatic cancer and germline CDKN2A mutations.
Goldstein AM
Hum Mutat; 2004 Jun; 23(6):630. PubMed ID: 15146471
[TBL] [Abstract][Full Text] [Related]
10. A carrier of both MEN1 and BRCA2 mutations: case report and review of the literature.
Ghataorhe P; Kurian AW; Pickart A; Trapane P; Norton JA; Kingham K; Ford JM
Cancer Genet Cytogenet; 2007 Dec; 179(2):89-92. PubMed ID: 18036394
[TBL] [Abstract][Full Text] [Related]
11. No evidence for germline mutations of the LKB1/STK11 gene in familial pancreatic carcinoma.
Grützmann R; McFaul C; Bartsch DK; Sina-Frey M; Rieder H; Koch R; McCarthy E; Greenhalf W; Neoptolemos JP; Saeger HD; Pilarsky C
Cancer Lett; 2004 Oct; 214(1):63-8. PubMed ID: 15331174
[TBL] [Abstract][Full Text] [Related]
12. Familial pancreatic cancer syndromes.
Habbe N; Langer P; Sina-Frey M; Bartsch DK
Endocrinol Metab Clin North Am; 2006 Jun; 35(2):417-30, xi. PubMed ID: 16632103
[TBL] [Abstract][Full Text] [Related]
13. Intraductal papillary mucinous neoplasm of the pancreas: associated cancers, family history, genetic predisposition?
Lubezky N; Ben-Haim M; Lahat G; Marmor S; Solar I; Brazowski E; Nackache R; Klausner JM
Surgery; 2012 Jan; 151(1):70-5. PubMed ID: 21975290
[TBL] [Abstract][Full Text] [Related]
14. International registries of families at high risk of pancreatic cancer.
Greenhalf W; Malats N; Nilsson M; Bartsch D; Neoptolemos J
Pancreatology; 2008; 8(6):558-65. PubMed ID: 18818508
[TBL] [Abstract][Full Text] [Related]
15. [Genetics of pancreatic cancer: recent advances in molecular diagnosis].
Hayashi N; Egami H; Ogawa M
Nihon Geka Gakkai Zasshi; 2002 Jun; 103(6):476-81. PubMed ID: 12094699
[TBL] [Abstract][Full Text] [Related]
16. Familial pancreatic cancer.
Klein AP; Hruban RH; Brune KA; Petersen GM; Goggins M
Cancer J; 2001; 7(4):266-73. PubMed ID: 11561603
[TBL] [Abstract][Full Text] [Related]
17. Hereditary pancreatitis and secondary screening for early pancreatic cancer.
Vitone LJ; Greenhalf W; Howes NR; Neoptolemos JP
Rocz Akad Med Bialymst; 2005; 50():73-84. PubMed ID: 16358943
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: deleterious BRCA2 mutations in 17%.
Murphy KM; Brune KA; Griffin C; Sollenberger JE; Petersen GM; Bansal R; Hruban RH; Kern SE
Cancer Res; 2002 Jul; 62(13):3789-93. PubMed ID: 12097290
[TBL] [Abstract][Full Text] [Related]
19. Hereditary ovarian cancer.
Prat J; Ribé A; Gallardo A
Hum Pathol; 2005 Aug; 36(8):861-70. PubMed ID: 16112002
[TBL] [Abstract][Full Text] [Related]
20. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families.
Grocock CJ; Rebours V; Delhaye MN; Andrén-Sandberg A; Weiss FU; Mountford R; Harcus MJ; Niemczyck E; Vitone LJ; Dodd S; Jørgensen MT; Ammann RW; Schaffalitzky de Muckadell O; Butler JV; Burgess P; Kerr B; Charnley R; Sutton R; Raraty MG; Devière J; Whitcomb DC; Neoptolemos JP; Lévy P; Lerch MM; Greenhalf W;
Gut; 2010 Mar; 59(3):357-63. PubMed ID: 19951905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]